Related Experiment Video
Updated: Nov 18, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Characterizing Advanced Parkinson's Disease: Romanian Subanalysis from the OBSERVE-PD Study
Jozsef Attila Szasz1, Dragos Catalin Jianu2, Mihaela Adriana Simu2
1Department of Neurology, Mureș Emergency Clinical County Hospital, "George Emil Palade" University of Medicine, Pharmacy, Science and Technology, Târgu Mureș 540139, Romania.
Many Parkinson's disease patients have advanced Parkinson's disease (APD), showing a higher burden of symptoms and complications. Earlier recognition of APD is crucial for better patient outcomes and treatment access.
Area of Science:
- Neurology
- Clinical Research
- Observational Studies
Background:
- Parkinson's disease (PD) progression varies, with a subset developing advanced Parkinson's disease (APD).
- Understanding the prevalence and clinical characteristics of APD is essential for optimizing patient care.
Purpose of the Study:
- To determine the proportion of patients with APD versus non-APD in Movement Disorders Centers (MDCs).
- To assess the clinical burden of APD, including motor and non-motor symptoms, quality of life, and treatment complications.
- To evaluate the agreement between physician judgment and established indicators for APD diagnosis.
Main Methods:
- Cross-sectional, multicountry observational study (OBSERVE-PD) involving 2615 PD patients across 18 countries.
- Data collected via single visits between February 2015 and January 2016.
- Assessment included clinical judgment of APD, fulfillment of APD indicators, motor/non-motor symptoms, daily activities, treatment complications, quality of life, and device-aided therapy (DAT) eligibility.
Main Results:
- In Romanian patients (n=161), 59.0% were diagnosed with APD, and 78.8% met at least one APD indicator.
- Moderate agreement was observed between physician judgment and APD indicators.
- Patients with APD exhibited a significantly higher burden of motor symptoms, non-motor symptoms, treatment complications, and lower quality of life compared to non-APD patients.
- Physicians deemed 73.7% of APD patients eligible for DAT, yet 54.3% of eligible patients did not receive it.
Conclusions:
- Earlier recognition of APD, integrating clinical judgment with standardized criteria, is vital.
- Timely APD diagnosis alone is insufficient; patient acceptance and access to appropriate treatments like DAT are critical for improving outcomes.
- The study underscores the need for improved diagnostic tools and treatment accessibility for advanced Parkinson's disease.
More Related Videos
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation